Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Mylan Laboratories Limited - Unit 8 in November 2019 concerns drug manufacturing or product quality issues, though the specific violations cannot be determined without the full letter text. The warning falls under FDA's drug regulatory authority, but the particular compliance concerns and the specific issuing office are not identified in the available metadata. Without access to the complete warning letter, the nature and scope of the violations remain unspecified.